NCT02153398 - A Phase I/III Study of D961H 10 mg and 20 mg in Japanese Paediatric Patients With Gastrointestinal Acid Related Diseases | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

June 30, 2014

Primary Completion Date

April 30, 2016

Study Completion Date

April 30, 2016

Conditions

Gastric Ulcer (GU)Duodenal Ulcer (DU)Anastomotic Ulcer (AU)Non-erosive Reflux Esophagitis Disease (NERD)Reflux Esophagitis (RE)Zollinger-Ellison Syndrome

Interventions

DRUG

D961H sachet 10 mg

DRUG

D961H capsule 10mg

DRUG

D961H capsule 20 mg

Trial Locations (15)

Unknown

Research Site, Bunkyō City

Research Site, Fukuoka

Research Site, Hiroshima

Research Site, Izumi-shi

Research Site, Maebashi

Research Site, Matsumoto-shi

Research Site, Osaka

Research Site, Saitama-shi

Research Site, Sapporo

Research Site, Setagaya-ku

Research Site, Shimotsuke-shi

Research Site, Shinjuku-ku

Research Site, Suzaka-shi

Research Site, Ureshino-shi

Research Site, Yokohama